Smartscope-X - Affordable, accessible and automatic screening solution for diabetic retinopathy

  • Research and Innovation
  • Global
  • Cloud
Last updated: 2021-10-28 01:59

EU Contribution
  • €1,971,935.00
Overall Budget
  • €2,817,050.00

Stakeholders


    Industry
  • Finland
    OPTOMED OY (Finland)

Strategic Goals

As the number of diabetics grows, so too does the number of people who suffer from diabetic retinopathy (DR). Caused by damage to the blood vessels in the tissues at the back of the eye, DR is the most common cause of vision loss in working-age adults.

Solutions Developed / Used

Smartscope-X consists of three main components: a low-cost handheld fundus camera, an automated screening algorithm and cloud service for fundus images. With this unique combination, Optomed’s vision is to bring affordable, accessible and automatic DR screening available for all diabetics. In this project, the key ambition is to validate and commercialise Smartscope-X solution.

Description

Start Date

01/08/2017

End Date

30/04/2020

Geographical Scope

  • Global

Keywords

  • Cloud

Project Life-Cycle Stage

  • Research and Innovation

Industry

  • Health

Technology

  • Artificial Intelligence / Machine Learning